Skip to content

Clinical trials

Phase 2 Atrial Fibrillation trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2 Country / region: Poland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20092
20121
20131
20141
20211
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
ARCA Biopharma, Inc.1
Acesion Pharma1
Advanz Pharma1
Anthos Therapeutics, Inc.1
Astellas Pharma Inc1
Bayer1
Gilead Sciences1
GlaxoSmithKline1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation14
Stroke2
Atrial Flutter1
Cardiovascular Diseases1
Heart Failure1
Ischemic Attack, Transient1
Pulmonary Embolism1
Thromboembolism1
Venous Thromboembolism1
Venous Thrombosis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.